The business strategy of patent challenge in American generic drugs

The introduction challenge patent is not a technical issue, nor a legal issue, it is a business strategy "The challenge of patents is not that patents are flawed, but that challenges themselves can be profitable Patent litigation is to take advantage of the average opportunity of the law to gain profits; if you have enough chips in your hand and believe that you will win several, the inevitable result is: the more you bet, the more you win " Martin Voet "generic drug challenge patents" 2014 Directory: one of the business strategies for patent challenges in the US generic drugs (1) Exclusive drug ownership and drug price bubbles two Challenge patents are the tools to pierce the price bubble (three) the patent challenge business strategy of the US generic drugs (two) three Challenge the patent procedures and judicial structure four Examples of patent concepts and techniques business strategy of patent challenge in American generic drugs (3) 6 Business strategy of patent challenge in American generic drugs (4) 7 Statistics of patent litigation results 8 Business value of patent challenge in American generic drugs (5) 9 Risk of patent challenge 10、 Conclusion of patent challenge case analysis: what is "challenging patent"? What is challenge patent? For example: you build a house and lock the door After a while, whoever can open the lock will live in it legally You'll say it's unfair I built the house and paid for it Why can they live as long as they can unlock the lock? Yes, no one likes to make such a housing bill But in the pharmaceutical industry, this is true! As long as generic drugs can open the patent lock, they can use the documents and data submitted to FDA for free In fact, the first attempt to unlock generic drugs (FTF) was granted a certain period of exclusive right (180 days exclusive right), which is to encourage generic drugs to do so! ——Translated from: Martin voet's "generic challenge patent" 2014 challenge patent is the finishing touch of the reform of generic drug legislation in 1984 This law not only encourages drug innovation, but also speeds up the market entry of generic drugs, thus greatly reducing the drug price Patent challenge is a sharp weapon to pierce the price bubble of drugs, and it is also a golden springboard to be based on the American generic drug market Author: Meng Bayi mobile number: 13220385722 (with wechat) contact email: bayi.meng@yahoo.com